Enzymotec Boosts Production Capacity

Enzymotec announces today increasing its production capacity due to the success of its innovative product line for dietary supplements and functional foods.

"The company made significant investments in expanding its Israeli site, in order to meet our customers’ needs for an efficient supply on time and by thus strengthening our key market position”, says Dr. Ariel Katz, CEO of Enzymotec. “We decided to increase the production capacity in order to answer the expected increasing in the demand from both dietary supplements and functional food producers in several categories.”

Enzymotec’s innovative line includes: SharpPSTM line, a lecithin-derived cognitive enhancer, InFat, a structured lipid that significantly improves calcium absorption and energy intake of newborns: CardiaBeat™, an innovative nutrient that can simultaneously reduce all CVD risk factors including: “bad” cholesterol (LDL), triglycerides and oxidative stress.

Enzymotec produces products under the highest standards and regulations, including HACCP, GMP, ISO and Kosher

Enzymotec is a biotech company, which develops advanced, innovative lipid-based ingredients for the nutraceuticals and functional foods markets.

Contact Person:
Ms. Sagit Betser
Marketing Manager
Enzymotec Ltd.
E-mail: [email protected]
Fax: +972-4-6443799

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.